GlassScriptPhysician profile
Frank H Moore
NPI 1477549863
$9,212.18
in general payments reported to CMS, 2019-2025
45 companies · $1,140 in 2025
The $1,140 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,382 · 2020: $526 · 2021: $1,733 · 2022: $1,004 · 2023: $1,065 · 2024: $1,363 · 2025: $1,140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,263 · Education: $190 · Grant: $114.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,263.42 |
| Education | $190.19 |
| Grant | $113.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $1,500.31 | 2019-2020 | |
| Astellas Pharma US INC | $1,112.65 | 2019-2025 | Xtandi |
| Abbvie INC. | $983.60 | 2019-2025 | |
| Dendreon Pharmaceuticals LLC | $504.38 | 2019-2025 | Provenge |
| Teleflex LLC | $494.26 | 2021-2024 | Urolift |
| Boston Scientific Corporation | $486.01 | 2019-2025 | Spaceoar Vue System - 10ml |
| Janssen Biotech, INC. | $429.68 | 2019-2024 | Erleada |
| Blue Earth Diagnostics | $365.15 | 2019-2025 | Posluma |
| Myovant Sciences INC. | $319.97 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $250.56 | 2023-2025 | Orgovyx |
| Procept Biorobotics Corporation | $209.44 | 2021-2025 | Aquabeam System |
| Bayer Healthcare Pharmaceuticals INC. | $201.59 | 2020-2025 | |
| Merck Sharp & Dohme LLC | $185.40 | 2022-2025 | Keytruda, Lynparza, Welireg |
| Urogen Pharma, INC. | $167.02 | 2020-2025 | |
| Immunitybio, INC. | $158.89 | 2025 |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $148.06 | 2022-2025 | Pylarify |
| Olympus America INC. | $142.35 | 2024-2025 | Itind System |
| Urovant Sciences INC | $130.02 | 2022 | |
| Impulse Dynamics (USA) INC. | $115.87 | 2023 | Optimizer |
| Tolmar Pharmaceuticals, INC. | $109.51 | 2019-2022 | |
| Innovation Technologies INC | $109.15 | 2023 | Irrisept |
| Ferring Pharmaceuticals INC. | $98.48 | 2019 | |
| Travere Therapeutics, INC. | $88.84 | 2019-2021 | |
| Biotissue Holdings INC. | $88.10 | 2023 | |
| Endo Pharmaceuticals INC. | $86.72 | 2020-2022 | |
| Genzyme Corporation | $78.37 | 2019 | |
| Myriad Genetic Laboratories, INC. | $67.51 | 2021-2024 | Prolaris |
| Axonics, INC. | $60.33 | 2024 | Bulkamid |
| Clarus Therapeutics INC. | $55.47 | 2021 | |
| Mission Pharmacal Company | $54.49 | 2019-2024 | Uribel Tabs |
| Tolmar, INC. | $48.48 | 2023-2025 | Eligard, Jatenzo |
| Laborie Medical Technologies Corp. | $46.40 | 2022-2024 | Optilume Bph Drug Coated Balloon Catheter |
| Coloplast Corp | $39.27 | 2021 | |
| Steris Corporation | $37.31 | 2024 | |
| Accord Healthcare, INC. | $34.22 | 2022-2024 | |
| Calyxo, INC. | $32.47 | 2024 | Cvac Aspiration System |
| Astrazeneca Pharmaceuticals LP | $31.18 | 2022-2023 | Lynparza |
| Angiodynamics, INC. | $25.05 | 2024 | Nanoknife |
| Covidien LP | $19.44 | 2019 | |
| Civco Medical Instruments | $19.07 | 2024 | |
| Pfizer INC. | $18.07 | 2023 | |
| Verity Pharmaceuticals INC. | $16.99 | 2024 | Trelstar |
| Photocure INC | $15.62 | 2024 | Cysview |
| Medtronic, INC. | $13.69 | 2023 | Interstim |
| Antares Pharma, INC. | $12.74 | 2023 | Nocdurna, Tlando, Xyosted |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.